Abstract | CONTEXT: CLINICAL CASES: CONCLUSION: The association of TMA, especially TTP, and multiple myeloma is exceptional. The authors report such a case that induced irreversible renal damage, but with stable clinical and laboratory parameters with a follow-up of 4 years.
|
Authors | Hubert Yao, Matthieu Monge, Marianne Renou, Caroline Lecaque, Maïté Jauréguy, Claire Presne, Raïfah Makdassi, Gabriel Choukroun |
Journal | Clinical nephrology
(Clin Nephrol)
Vol. 81
Issue 3
Pg. 210-5
(Mar 2014)
ISSN: 0301-0430 [Print] Germany |
PMID | 23073062
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Autoantibodies
- Immunoglobulin G
- Dexamethasone
- ADAM Proteins
- ADAMTS13 Protein
- ADAMTS13 protein, human
- Melphalan
|
Topics |
- ADAM Proteins
(immunology)
- ADAMTS13 Protein
- Acute Kidney Injury
(immunology, therapy)
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Autoantibodies
(blood)
- Dexamethasone
(administration & dosage)
- Female
- Humans
- Immunoglobulin G
(blood)
- Melphalan
(administration & dosage)
- Multiple Myeloma
(blood, complications, diagnosis, immunology, therapy)
- Plasmapheresis
- Purpura, Thrombotic Thrombocytopenic
(blood, diagnosis, immunology, therapy)
- Renal Dialysis
- Time Factors
- Treatment Outcome
|